IBRX
IBRX
US45256X1037
ImmunityBio, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
11.14B EUR
9.22B EUR
8.03B EUR
2B EUR
Enterprise Value
11.37B EUR
9.96B EUR
8.55B EUR
2.43B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-75.07x
--
--
--
Price to Sales
67.19x
55.62x
56.98x
20.7x
Price to Book
--
--
--
--
EV/Revenue
68.61x
60.07x
60.63x
25.14x
EV/EBITDA
-48.34x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.67%
-3.13%
-3.73%
-11.09%
ende